Willingness to receive a booster dose of inactivated coronavirus disease 2019 vaccine in Taizhou, China.

Abstract

PURPOSE:

This population-based study aimed to determine the willingness to receive a booster dose of vaccine against coronavirus disease (COVID-19) in Taizhou, China.

METHODS:

An online questionnaire investigation addressing participants' willingness to receive a booster dose of the COVID-19 vaccine was organized in Taizhou, China. Of the 2318 interviewees who received the invitation, 1576 finished a qualifying questionnaire, corresponding to a response rate of 68.0%.

RESULTS:

The majority of respondents (n = 1435 [91.1%]) were willing to accept a booster vaccination against COVID-19. History of allergic reaction to other vaccines (OR = 0.30), confidence in the safety of the COVID-19 vaccines (OR = 3.20), confidence in the effectiveness of the COVID-19 vaccines against SARS-CoV-2 (OR = 2.25) and its variants (useful versus [vs.] useless, OR = 2.33), and vaccine recipients (OR = 3.09) remained significantly associated with willingness to accept a booster dose of COVID-19 vaccines.

CONCLUSION:

A moderate proportion of the participants who responded were willing to receive a booster dose of the COVID-19 vaccine. These results are valuable for starting health education and interventions to accelerate vaccine uptake and improve public health outcomes during the COVID-19 pandemic in China.

• Authors: Tao-Hsin Tung, Xiao-Qing Lin, Yan Chen, Mei-Xian Zhang, Jian-Sheng Zhu
• Journal: Expert review of vaccines (Expert Rev Vaccines) Vol. 21 Issue 2 Pg. 261-267 (Feb 2022) ISSN: 1744-8395 [Electronic] England
• PMID: 34894991 (Publication Type: Journal Article)

Chemical References

• COVID-19 Vaccines

Topics

• COVID-19
• COVID-19 Vaccines
• China (epidemiology)
• Cross-Sectional Studies
• Humans
• Pandemics
• SARS-CoV-2
• Vaccination